RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6
RxSight (NASDAQ: RXST) will report first-quarter 2026 financial results on May 6, 2026 after market close.
Rhea-AI Summary
RxSight (NASDAQ: RXST) will report first-quarter 2026 financial results on May 6, 2026 after market close.
Management will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET with dial-in numbers and a listen-only webcast on the company investor relations site; an archived recording will be posted after the call.
Positive
- None.
Negative
- None.
Details
News Market Reaction – RXST
In the Apr 23 session, RXST declined 2.70%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Earnings release date
- May 6, 2026
- Q1 2026 financial results after market close
- Conference call time PT
- 1:30 p.m. PT
- Start time for Q1 2026 results call
- Conference call time ET
- 4:30 p.m. ET
- Start time for Q1 2026 results call
- US toll-free dial-in
- (800) 715-9871
- Participant dial-in number for the call
- International dial-in
- (646) 307-1963
- Alternate participant dial-in number
- Conference code
- 2630350
- Access code for earnings conference call
Previous Earnings date Reports
-
Announced Q4 and full-year 2025 results date and conference call details.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ALISO VIEJO, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., today announced that it will report financial results for the first quarter after the market close on Wednesday, May 6, 2026. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
To participate in the conference call, please dial (800) 715-9871 or (646) 307-1963, and enter the conference code: 2630350. The call will also be broadcast live in listen-only mode via a link on the company’s investor relations website at https://investors.rxsight.com/. An archived recording of the call will be available through the same link shortly after its completion.
About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+®, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.
Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.